Literature DB >> 11983203

Diagnostic value of peripheral blood T-cell activation and soluble IL-2 receptor for acute rejection in liver transplantation.

Andreas Lun1, Mi Young Cho, Christian Müller, Gerhard Staffa, Wolf Otto Bechstein, Cornelia Radke, Peter Neuhaus, Harald Renz.   

Abstract

BACKGROUND: T-cells play an important role in the pathogenesis of rejection. Monitoring T-cells activation markers in peripheral blood may contribute to diagnosis of acute rejection after liver transplantation (LTX).
METHODS: Lymphocyte subset distribution, expression of T-cell activation markers (flow cytometry), concentration of soluble (s) interleukin-2 receptor (IL-2R) (solid phase chemiluminescence immunoassay), and liver enzymes as well as bilirubin were prospectively tested in peripheral blood samples of LTX patients with (n=69) and without acute rejection (n=50). Acute rejection was assessed by standard criteria including liver biopsies.
RESULTS: Intra-individual monitoring of immune parameters revealed an up-regulation of IL-2 receptor (CD25) expression on CD4 and CD8 T-cells together with increases in sIL-2R levels in patients with acute rejections. Measuring sIL-2R levels resulted in highest diagnostic efficiency (>85%). This level of diagnostic efficiency was not reached by any other marker tested. From all conventional markers of hepatocellular integrity and function, alkaline phosphatase reached the highest level of diagnostic efficiency with 70%.
CONCLUSIONS: Monitoring of up-regulation of the IL-2/IL-2R pathway represents a useful tool for assessment of acute rejection after LTX.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983203     DOI: 10.1016/s0009-8981(02)00045-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Diagnostic Biomarkers to Diagnose Acute Allograft Rejection After Liver Transplantation: Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies.

Authors:  Felix Krenzien; Eriselda Keshi; Katrin Splith; Silvan Griesel; Kaan Kamali; Igor M Sauer; Linda Feldbrügge; Johann Pratschke; Annekatrin Leder; Moritz Schmelzle
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

2.  Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.

Authors:  Laura Codarri; Laure Vallotton; Donatella Ciuffreda; Jean-Pierre Venetz; Miguel Garcia; Karine Hadaya; Leo Buhler; Samuel Rotman; Manuel Pascual; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2007-06-25       Impact factor: 14.307

3.  The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.

Authors:  Liang Ma; Huimao Zhang; Kebang Hu; Guoyue Lv; Yaowen Fu; Desalegn Admassu Ayana; Pingwei Zhao; Yanfang Jiang
Journal:  BMC Immunol       Date:  2015-09-23       Impact factor: 3.615

4.  Assessment of Immunological Biomarkers in the First Year after Heart Transplantation.

Authors:  Maja-Theresa Dieterlen; Katja John; Hartmuth B Bittner; Meinhard Mende; Attila Tarnok; Friedrich W Mohr; Markus J Barten
Journal:  Dis Markers       Date:  2015-09-30       Impact factor: 3.434

5.  Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?

Authors:  Aliede E In 't Veld; Hendrika W Grievink; Mahdi Saghari; Frederik E Stuurman; Marieke L de Kam; Aiko P J de Vries; Brenda C M de Winter; Jacobus Burggraaf; Adam F Cohen; Matthijs Moerland
Journal:  Int J Mol Sci       Date:  2019-09-23       Impact factor: 5.923

6.  Encapsulated three-dimensional bioprinted structure seeded with urothelial cells: a new construction technique for tissue-engineered urinary tract patch.

Authors:  Yi-Peng Jin; Chong Shi; Yuan-Yi Wu; Ji-Lei Sun; Jiang-Ping Gao; Yong Yang
Journal:  Chin Med J (Engl)       Date:  2020-02-20       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.